Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
san francisco blog main
8
×
biotech
boston blog main
life sciences
new york blog main
san francisco top stories
startups
boston top stories
national top stories
raleigh-durham blog main
boston
boulder/denver blog main
clinical trials
deals
fda
indiana blog main
investing
national
san diego blog main
seattle blog main
software
vc
venture capital
cancer
cancer diagnostics
detroit blog main
drug development
freenome
grail
liquid biopsy
medical device
medtech
new york top stories
novartis
raleigh-durham top stories
roboticsai
san francisco
texas blog main
texas top stories
What
developing
8
×
company
blood
ipo
medicines
new
tests
based
cancer
drugs
fda
investors
medical
plans
startup
therapeutics
activity
adds
affects
aims
americans
analyzes
announced
approach
approvals
approved
area
bay
beta
bio
biogen
bionics
biopsy
biotech
broader
buildout
business
called
ceo
clamped
Language
unset
Current search:
developing
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
5 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
6 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO